Evaluating lung MRI and synthetic CT for lung nodule follow-up
Official title: Performance of Lung MRI Combined to Synthetic CT in the Follow-up of Lung Nodules
Run by University Hospital, Bordeaux · NCT06825078 · Data updated 2026-11-12
This study is testing if a new way of using lung MRI with synthetic CT can safely monitor lung nodules in high-risk people, like heavy smokers, without the need for invasive tests or repeated radiation exposure.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 55 Years to 74 Years |
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | University Hospital, Bordeaux Academic / other |
| Drugs / interventions | radiation |
| Locations | 1 site (Pessac) |
| Status | Recruiting |
| Started | February 12, 2025 |
| Main results expected | February 2029 |
| Study ends | February 2029 |
| Registry record updated | July 9, 2026 |
| Trial ID | NCT06825078 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are individuals aged 55 to 74 with a significant smoking history and at least one lung solid nodule of 5mm or larger.
✕Probably not a fit
Patients with a history of lung cancer, severe comorbidities, or contraindications to MRI will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to assess the effectiveness of multiparametric lung MRI combined with synthetic CT in monitoring lung nodules in high-risk individuals, particularly heavy smokers or those exposed to carcinogens. The approach seeks to reduce the risks associated with invasive diagnostic methods and the exposure to ionizing radiation from repeated chest CT scans. By utilizing advanced MRI techniques, the study hopes to provide a non-invasive alternative for lung cancer diagnosis and follow-up. The study is a prospective pilot conducted at a single center, following recommendations from health authorities to explore new lung cancer screening methods.
Why it matters
Potential benefit: If successful, this study could provide a safer and more accurate method for monitoring lung nodules, potentially reducing unnecessary invasive procedures.
How similar studies have gone: Previous studies have indicated that MRI can be a viable alternative to CT for lung nodule assessment, suggesting potential success for this novel approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Subject aged between 55 and 74 years * High risk of developing lung cancer: by a combination of exposure to lung carcinogens and smoking (exposure to tobacco at the rate of 30 packs/year or cessation \< 15 years) * Presence of at least one lung solid nodule ≥ 5mm on the initial scan. * Subject able and willing to complete all scheduled visits and assessments. * Subject with health insurance. * Signed informed consent. Exclusion Criteria: * Subject with signs of lung cancer * Subject with history of lung cancer * Presence of severe life-threatening comorbidities at 6 months (recent CVA, recent discovery of advanced stage cancer) * Subject who had already undergone a chest scan less than a year previously * No exposure to occupational lung carcinogens according to the predefined criteria. * No exposure to tobacco or insufficient exposure to tobacco or cessation \> 15 years. * Contra-indication to MRI (Pace maker, implants, claustrophobia…) * Pregnant or breastfeeding woman * Poor understanding of French * Subject under legal protection
Where it's running
-
CHU Bordeaux
Pessac, France Recruiting
Study contacts
- Study coordinator: Ilyes Benlala, MD
- Email: ilyes.ben-lala@chu-bordeaux.fr
- Phone: +335 57 65 65 42
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
ePRO in advanced lung cancer: emotional distress, brain metastasis, and symptom burden
This study tests how patients with advanced lung cancer—some with brain metastases—report emotional distress and symptoms over time using electronic questionnaires.
-
Urine VOC Test to Detect Lung Cancer in Never Smokers
A urine test that looks for volatile compounds is tested to see if it can help detect lung cancer in adults who have never smoked.
-
SI-B036 safety test in advanced and metastatic solid tumors
This early-phase study checks whether SI-B036 is safe and tolerable in adults with advanced or metastatic solid cancers who have had prior therapy.
-
Guaraná Supplement for Cancer-Related Fatigue in People Undergoing Treatment
This study tests whether taking guaraná capsules helps reduce cancer-related fatigue and improve quality of life in adults with breast, lung, colorectal, or gastric cancer who are actively receiving treatment.
-
ENPP1/cGAS and FAP in Solid Tumors in Vietnamese Patients
This Vietnam-based study will test ENPP1, cGAS, and FAP expression in archived tumor samples from Vietnamese adults with solid cancers using immunohistochemistry.
-
Olive oil before lung cancer surgery to see if it lowers chylothorax
This study tests whether drinking 40 mL of extra-virgin olive oil a few hours before lung cancer surgery can reduce chylothorax after tumor removal.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.